Different inhibitory effect of imatinib on phosphorylation of mitogen‐activated protein kinase and Akt and on proliferation in cells expressing different types of mutant platelet‐derived growth factor receptor‐α
Akiko Ohashi(The University of Osaka), Seiichi Hirota(Hyogo Medical University)
Cited by 17
Related Papers
Secondary mutations in the kinase domain of the <i> KIT</i> gene are predominant in imatinib‐resistant gastrointestinal stromal tumor
|Cancer Science|2008|111
Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation
|Laboratory Investigation|2007|65
Epithelioid glioblastoma with microglia features: potential for novel therapy
|Brain Pathology|2020|13
In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice
|Laboratory Investigation|2009|9